Health ❯Healthcare ❯Vaccines

COVID-19 Vaccines

Novavax Nuvaxovid Moderna Vaccine Novavax Vaccine FDA Approval Moderna Moderna Spikevax 2024-2025 Vaccine Updates mRNA Vaccines KP.2 Variant Vaccines Updated Vaccination Guidelines

FDA Science Chief Overrides Vaccine Approvals, Launches Muscular Dystrophy Drug Review

Documents reveal Dr. Vinay Prasad countermanded about 30 FDA reviewers to narrow vaccine eligibility after deeming the COVID-19 threat diminished.

FDA Approves Moderna’s mNEXSPIKE for High-Risk Populations

FDA Approves Moderna’s mNEXSPIKE for Seniors and High-Risk Adults as CDC Drops Recommendations for Healthy Children and Pregnant Women

Zachary Levi Faces Hollywood Fallout Over Trump Support and Vaccine Skepticism

FDA Expands Myocarditis Warnings for COVID-19 Vaccines Amid Senate Scrutiny

FDA Grants Limited Approval to Novavax’s COVID-19 Vaccine

HHS Implements Controversial Vaccine Trial Mandate Under RFK Jr.

Moderna Cuts 2025 Revenue Forecast by $1 Billion, Shares Drop Over 20%

Novavax Shares Fall as Revenue Forecast Slashed Again

Moderna Reports Unexpected Profit on Strong COVID Vaccine Sales

FDA Halts Novavax's COVID-Flu Combo Vaccine Trial Over Safety Concerns

Trudeau Attends Francophonie Summit Amid Middle East Tensions

Canada Declines Novavax COVID-19 Vaccine Due to Low Demand

Health Canada Approves Pfizer's Updated COVID-19 Vaccine

Health Canada Approves Moderna's Updated COVID-19 Vaccine

FDA Authorizes New Novavax Vaccine Targeting Omicron Variant

New COVID-19 and Flu Vaccines Approved and Rolling Out Nationwide

FDA Approves Updated COVID-19 Vaccines Targeting New Variants

COVID-19 Vaccinations Linked to Reduced Heart Attack and Stroke Risks

Moderna Lowers Annual Sales Forecast Amid Competitive Vaccine Market